000 01243 a2200349 4500
005 20250517041708.0
264 0 _c20160516
008 201605s 0 0 eng d
022 _a1757-790X
024 7 _a10.1136/bcr-2015-211160
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGupta, Arjun
245 0 0 _aIpilimumab-associated colitis or refractory Clostridium difficile infection?
_h[electronic resource]
260 _bBMJ case reports
_cJul 2015
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aClostridioides difficile
_xdrug effects
650 0 4 _aColitis
_xchemically induced
650 0 4 _aDiarrhea
_xdrug therapy
650 0 4 _aEnterocolitis, Pseudomembranous
_xcomplications
650 0 4 _aFluid Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aIpilimumab
650 0 4 _aMale
650 0 4 _aMethylprednisolone
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aKhanna, Sahil
773 0 _tBMJ case reports
_gvol. 2015
856 4 0 _uhttps://doi.org/10.1136/bcr-2015-211160
_zAvailable from publisher's website
999 _c25053651
_d25053651